Better Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	6.6	15.74	40.57	0.12	0.76
Cash & Short-Term Investments	6.6	15.74	40.57	0.12	0.76
Cash Growth	-70.42%	-61.20%	32880.49%	-83.75%	-
Other Receivables	0.07	0.05	0.28	0.22	-
Receivables	0.07	0.05	0.28	0.22	-
Prepaid Expenses	0.67	2.5	4.41	0.12	0.23
Other Current Assets	-	0.17	-	-	-
Total Current Assets	7.35	18.45	45.25	0.46	0.99
Property, Plant & Equipment	0.1	0.12	0.08	0.09	0.18
Other Intangible Assets	2.79	3.89	5.08	5.56	3.27
Other Long-Term Assets	0.48	0.49	0.55	0.28	0.44
Total Assets	10.72	22.94	50.96	6.39	4.88
Accounts Payable	2.31	3.04	1.52	0.51	0.34
Accrued Expenses	4.04	5.93	3.21	0.1	0.15
Current Portion of Long-Term Debt	6.59	4.53	-	-	-
Total Current Liabilities	12.94	13.49	4.73	0.61	0.49
Long-Term Debt	7.72	10.35	9.51	0.64	5
Long-Term Deferred Tax Liabilities	-	-	-	0.15	-
Other Long-Term Liabilities	-	-	-	11.74	-
Total Liabilities	20.66	23.84	14.24	13.15	5.49
Common Stock	0	0	0	0	0.21
Additional Paid-In Capital	124.37	110.6	108.46	24.65	-
Retained Earnings	-134.31	-111.5	-71.74	-31.41	-25.02
Total Common Equity	-9.94	-0.9	36.72	-6.76	-24.81
Shareholders' Equity	-9.94	-0.9	36.72	-6.76	-0.61
Total Liabilities & Equity	10.72	22.94	50.96	6.39	4.88
Total Debt	14.31	14.88	9.51	0.64	5
Net Cash (Debt)	-7.71	0.86	31.06	-0.52	-4.24
Net Cash Growth	-	-97.23%	-	-	-
Net Cash Per Share	-0.26	0.04	2.39	-0.05	-0.89
Filing Date Shares Outstanding	47.4	23.85	23.61	5.7	4.74
Total Common Shares Outstanding	40.58	23.85	23.6	5.7	4.74
Working Capital	-5.59	4.95	40.52	-0.15	0.5
Book Value Per Share	-0.24	-0.04	1.56	-1.19	-5.23
Tangible Book Value	-12.73	-4.79	31.64	-12.31	-28.08
Tangible Book Value Per Share	-0.31	-0.20	1.34	-2.16	-5.92
Machinery	-	0.18	0.31	0.26	0.24
Leasehold Improvements	-	-	-	-	0.11

Source: S&P Capital IQ. Standard template. Financial Sources.